TRIPLE NEGATIVE BREAST CANCER VACCINES
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75N91026F00001
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $1,147,754
- Period of performance
- Sep 14, 2026 – Sep 13, 2028
Public award description
TRIPLE NEGATIVE BREAST CANCER VACCINES
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Contractor: UNIVERSITY OF OKLAHOMA
- Agency: Department of Health and Human Services
- Federal market intelligence software
Related Federal Awards
Recompete monitoring
Awards approaching a documented period-of-performance end date. Related forecasts or opportunities are linked only when explicit references or strong deterministic signals match — expiration alone is not a confirmed recompete.
- Period ends
- Sep 13, 2028 (691 days)
- Evidence status
- FORECAST IDENTIFIED
- Evidence score
- 50 (deterministic, not pWin)
- Forecast evidence
- Matched forecast
Supporting evidence
- FACT: Award period end date — 2028-09-13
- FACT: Award start date — 2026-09-14
- DERIVED: Days until period end — 691
- FACT: Award recipient (incumbent on this award) — UNIVERSITY OF OKLAHOMA
- FACT: Awarding agency — Department of Health and Human Services
- FACT: Award amount (obligated/total as stored) — 1147754